Table 3.

Club Urológico Español de Tratamiento Oncológico scoring model or statistically significant clinicopathological criteria in univariate analysis among patients with intermediate- or high-risk non–muscle-invasive bladder cancer who received bacillus Calmette-Guérin (N=183) +1 to 180 days after induction.

Clinicopathological criterion	Missinga, n (%)	Recurrence (Mann-Whitney U test)
Neutrophil count	73 (60.1)	0.009
Derived neutrophil-to-lymphocyte ratio	73 (60.1)	0.03
CUETOb, continuous	182 (99.5)	0.10
CUETO, categoricalc	182 (99.5)	0.07
CUETO, gender	182 (99.5)	0.61
CUETO, number of tumors	182 (99.5)	0.05
CUETO, CISd	182 (99.5)	0.33
CUETO, high-grade tumor	182 (99.5)	0.34
CUETO, age	183 (0)	0.75

^aWe have complete data for CUETO and age (N=183), and 0% of the data are missing. For other CUETO, we have data for 182 patients, and the data are 99.5% complete. We have 60.1% of data (from 73 patients) for neutrophil count within that time span, with 39.9% not having a recorded lab test for this in the timespan.

^bCUETO: Club Urológico Español de Tratamiento Oncológico.

^cCUETO, categorical: ≤4, 0 points; 5 or 6, 1 point; 7-9, 2 points; and ≥10, 3 points.

^dCIS: carcinoma in situ.